Tuesday, May 14, 2019

Vuzix Partners with VSee Lab Inc. to Deliver a Telehealth and Telemedicine Smart Glasses Solution

Source:  Vuzix Corporation 4/9/19

Vuzix® Corporation (NASDAQ: VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, is pleased to announce a strategic partnership with VSee Lab Inc. ("VSee"), a San Jose-based video telehealth company, to introduce a telehealth and telemedicine smart glasses solution for Vuzix' M300XL and Vuzix Blade Smart Glasses.

VSee provides a HIPAA-compliant video telehealth and telemedicine video conferencing solution that is used by more than 1,000 telemedicine companies operating all over the globe, including MDLIVE, Walgreens, McKesson, International SOS and DaVita, as well as numerous A-list healthcare systems such as Ascension, HealthPartners, Sutter, Trinity and Sentara. VSee was also selected by NASA to be the exclusive video conference solution on the International Space Station (ISS) because of its usability and its ability to adapt to poor network conditions.  It has been used by astronauts on board the ISS since 2014.

"The VSee telemedicine video conferencing platform is easy and simple to use.  We are excited to offer a telemedicine video conferencing smart glasses hardware option to our existing customers, first responders and to VSee's extensive telemedicine customer base," said Paul Travers, President and Chief Executive Officer at Vuzix. 

"While VSee previously worked with some early generation smart glasses solutions, the technology was not ready for telemedicine. We feel very privileged now to be partnering with Vuzix with its mature smart glasses offerings. Telemedicine video conferencing through smart glasses from Vuzix is a natural progression from tablets and computers for our customers.  We are excited to begin realizing telehealth smart glasses applications from remote training on imaging technology (CTs, ultrasounds) and inserting IVs to telesurgery to AR-enhanced video visits.  We look forward to continued collaboration between our two companies," said Milton Chen, Chief Executive Officer at VSee.

VSee will be showcasing the smart glasses telehealth and telemedicine solution on the Vuzix M300XL and Vuzix Blade at the American Telemedicine Association (ATA) 2019 annual conference and expo in New Orleans April 14-16th in VSee booth #727.  More information can be found at http://www.ata2019.org/

The VSee telehealth and telemedicine solution for the Vuzix M300XL and Vuzix Blade Smart Glasses is expected to be commercially available during the second quarter of 2019.

About Vuzix Corporation
Vuzix is a leading supplier of Smart-Glasses and Augmented Reality (AR) technologies and products for the consumer and enterprise markets. The Company's products include personal display and wearable computing devices that offer users a portable high-quality viewing experience, provide solutions for mobility, wearable displays and augmented reality. Vuzix holds 153 patents and patents pending and numerous IP licenses in the Video Eyewear field. The Company has won Consumer Electronics Show (or CES) awards for innovation for the years 2005 to 2019 and several wireless technology innovation awards among others. Founded in 1997, Vuzix is a public company (NASDAQ: VUZI) with offices in Rochester, NY, Oxford, UK, Barcelona, Spain and Tokyo, Japan.  For more information, visit Vuzix website Twitter and Facebook pages.

About VSeeVSee is the video telehealth company behind NASA Space Station, Trinity, Ascension, DaVita, MDLIVE and 1,200+ customers, and the parent of This American Doc medical group—an airbnb-like marketplace for physician staffing. VSee empowers health organizations and practitioners to achieve better patient care and improved efficiency through simple, scalable telehealth. Its modular platform provides powerful flexibility for fast customization to a wide range of workflows from ER diversion to e-ICU to on-call specialist consults to chronic care management. Learn more at vsee.com.

No comments:

Post a Comment